RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Founded by Ron Seubert in 2009, RareCyte is backed by investors that include 5AM Ventures, HealthQuest Capital, Telegraph Hill Partners, and Ron Seubert and is headquartered in Seattle.